Publications

5674 Results

SWOG S0701 phase III randomized trial of three antibiotic regimens to eradicate Helicobacter pylori: efficacy and failure at one-year

Authors
LH Baker;JJ Crowley;M Valdivieso;R Dominguez;L Bravo;R Pena;M Meza-Montenegro;P Correa;W Chey;D Morgan;F Meyskens;G Goodman
Journal / Conference
Amercan Association of Cancer Research Annual Meeting, oral presentation (plenary); presentation # SY26-02;
Year
2012
Research Committee(s)
Prevention, Screening, and and Surveillance
Study Number(s)
S0701

Evaluation of vitamin E and selenium on the prevention of bladder cancer in SWOG-coordinated SELECT

Authors
Y Lotan;P Goodman;R Youssef;R Svatek;SF Shariat;C Tangen;IM Thompson;EA Klein
Journal / Conference
Journal of Urology, Vol. 187, No. 4S, Supplement, e515, #1273;American Urological Assn Annual Meeting (May 19-23, 2012, Atlanta, GA), poster;
Year
2012
Research Committee(s)
Prevention, Screening, and and Surveillance
Study Number(s)
S0000

Lower income patients less likely to participate in cancer clinical trials

Authors
J Unger;D Hershman;K Burg;C Moinpour;J Peterson;K Albain;J Crowley
Journal / Conference
AcademyHealth Annual Research Meeting (June 24-26, 2012, Orlando, FL), oral presentation;
Year
2012
Research Committee(s)
Cancer Care Delivery and Outcomes and Comparative Effectiveness

Challenges of collecting health data and maintaining contact with an aging study population

Authors
J Hartline;K Anderson;D Marrah;E Klein
Journal / Conference
Society for Clinical Trials 33rd Annual Meeting (May 20-23, 2012, Miami, FL), oral presentation;
Year
2012
Research Committee(s)
Prevention, Screening, and and Surveillance
Study Number(s)
S0000

Treatment of Helicobacter pylori in Latin America [correspondence; authors' reply]

Authors
ER Greenberg;GL Anderson;DR Morgan;J Torres;W Chey
Journal / Conference
Lancet 379:408-409
Year
2012
Research Committee(s)
Prevention, Screening, and and Surveillance
PMID
PMID21777974
PMC
PMC3313469
Study Number(s)
S0701

Combination anastrozole and fulvestrant in metastatic breast cancer: SWOG S0226

Authors
R Mehta;W Barlow;K Albain;T Vandenberg;S Dakhil;N Tirumali;DL Lew;DF Hayes;JR Gralow;R Livingston;GN Hortobagyi
Journal / Conference
New England Journal of Medicine 367(5):435-444;
Year
2012
Research Committee(s)
Breast
PMID
PMID22853014
PMC
PMC3951300
Study Number(s)
S0226

Impact of body-mass index in the outcome of adult patients with acute myeloid leukemia

Authors
B Medeiros;M Othus;EH Estey;M Fang;F Appelbaum
Journal / Conference
Haematologica 97(9):1401-1404
Year
2012
Research Committee(s)
Leukemia
PMID
PMID22315487
PMC
PMCID3436242
Study Number(s)
S0106, SWOG-8600, SWOG-9031, SWOG-9126, SWOG-9333, SWOG-9500, S9617, S9918

Randomized phase III study comparing paclitaxel/cisplatin/gemcitabine (PCG) and gemcitabine/cisplatin (GC) in patients with locally advanced or metastatic urothelial cancer without prior systemic therapy: EORTC intergroup study 30987

Authors
J Bellmunt;H von der Maase;GM Mead;N Skonecza;M DeSantis;G Daugaard;J Heyer;N Houede;L Paz-Ares;L Laufman;E Winquist;D Raghavan;S Marreaud;S Collette;R Sylvester;R de Wit
Journal / Conference
Journal of Clinical Oncology 30(10):1107-1113;
Year
2012
Research Committee(s)
Genitourinary
PMID
PMID22370319
PMC
PMC3341152
Study Number(s)
30987

Design of a phase III clinical trial with prospective biomarker validation: SWOG S0819

Authors
M Redman;J Crowley;R Herbst;F Hirsch;D Gandara
Journal / Conference
Clinical Cancer Research 18(15):4004-4012
Year
2012
Research Committee(s)
Lung
PMID
PMID:22592956
PMC
PMC3409929
Study Number(s)
S0819

Predictability of adjuvant trastuzumab benefit in N9831 patients using the ASCO/CAP HER2-positivity criteria [PMID22138096; PMC3260130]

Authors
EA Perez;AC Dueck;A McMullough;M Reinholz;K Tenner;N Davidson;J Gralow;LA Kutteh;DH Hillman;RB Jenkins;B Chen
Journal / Conference
Journal of the National Cancer Institute 104(2):159-162
Year
2012
Research Committee(s)
Breast
Study Number(s)
N9831